Eunpi Cho, MD
Hematology & Oncology · Sunnyvale
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Cho’s office at (408) 739-6000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A134218 · Current
Licensed to practise in California · since 2015 · expires 2026-11-30 · Johns Hopkins University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60273370Physician And Surgeon License · since 2012 · expires 2016-11-07ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 39 Part D prescriptions in 2018. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2018 | 39 | None | 0% (0) | 31% | $71,166 |
| 2017 | 342 | 64 | None | 24% | $759,733 |
| 2016 | 377 | 75 | 3% (12) | 20% | $539,772 |
| 2015 | 41 | 20 | 27% (11) | None | $12,335 |
| 2013 | 116 | 24 | None | None | $3,390 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2018: 1 drug
| Xarelto | 11 | $4,482 | $407 |
2017: 12 drugs
| Revlimid | 15 | $195,611 | $13,041 |
| Imatinib Mesylate | 21 | $170,214 | $8,105 |
| Imbruvica | 16 | $147,375 | $9,211 |
| Exemestane | 13 | $8,555 | $658 |
| Xarelto | 12 | $4,543 | $379 |
| Tamoxifen Citrate | 22 | $1,521 | $69 |
| Hydroxyurea | 32 | $1,468 | $46 |
| Anastrozole | 47 | $1,146 | $24 |
| Cyclosporine Modified | 11 | $1,098 | $100 |
| Acyclovir | 12 | $107 | $9 |
| Lorazepam | 13 | $60 | $5 |
| Gabapentin | 13 | $48 | $4 |
2016: 12 drugs
| Xtandi | 14 | $126,414 | $9,030 |
| Imbruvica | 11 | $111,393 | $10,127 |
| Revlimid | 13 | $102,611 | $7,893 |
| Xarelto | 16 | $5,643 | $353 |
| Anastrozole | 40 | $836 | $21 |
| Hydroxyurea | 20 | $576 | $29 |
| Loperamide | 12 | $317 | $26 |
| Dexamethasone | 17 | $205 | $12 |
| Acyclovir | 12 | $163 | $14 |
| Lorazepam | 26 | $120 | $5 |
| Prochlorperazine Maleate | 20 | $117 | $6 |
| Ondansetron | 11 | $82 | $7 |
Professional record
- NPI
- 1326223256
- Licence
- CA A134218, WA MD60273370California A134218: Current · expires 2026-11-30Washington MD.MD.60273370: Expired
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X)
- Mailing address
- 2350 W. El Camino Real, 2nd Floor, Mountain View, CA, 94040
- NPI first listed
- 2008-01-09
- NPI last updated
- 2015-07-27
This is when the NPI record was last certified, not a medical board exam.